Cirne Lima FK
Her 2 e EGFR em adenocarcinoma de estômago
45
82. Chan TO, Rittenhouse SE, Tsichilis PN. Akt/Pkb and other D3 phosphoinositide-regulated
kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev
Biochem 1999; 68:965-1014.
83. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. Akt phosphorylation of
BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91:231-41.
84. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, et al. Regulation of
cell death protease caspase-9 by phosphorylation. Science 1998; 282:1318-21.
85. Huang ZQ, Buchsbaum DJ, Raisch KP, Bonner JA, Bland KI, Vickers SM. Differential
responses by pancreatic carcinoma cell lines to prolonged exposure to Eritux (IMC-C225)
anti-EGFR antibody. J of Surg Res 2003; 111:274-83.
86. Masaki T, Hatanaka Y, Nishioka M, Tokuda M, Shiratori Y, Reginfo W, et al. Activation of
epidermal growh factor receptor kinase in gastric cacinoma: a preliminary study. Am J of
Gstroenterology 2000; 95 (8); letters 2135-6.
87. Yasui W, Tahara E, Tahara H, Fujimoto J, Naka K, Nakayama J, et al. Immunohistochemical
detection of human telomerase reverse transcriptase in normal mucosa and precanerous
lesions of the stomach. Jpn J Cancer Res 1999; 90:589-95.
88. Takehana T, Kunitomo K, Suzuki S, Kono K, Fujii H, Matsumoto Y, et al.
Expression of
epidermal growth factor receptor in gastric carcinomas. Clin Gastroenterol Hepatol.
2003;1(6):438-45.
89. Arteaga CL, Targeting Her1/EGFR: a molecular aproach to cancer therapy. Semin Oncol 2003;
3(7):3-14.
90. Dutra AP, Granja NV, Schmitt FC, Cassali GD.
c-erbB-2 expression and nuclear pleomorphism
in canine mammary tumors. Braz J Med Biol Res. 2004;37(11):1673-81.
91. Correa P. Is gastric cancer preventable ? Gut 2004; 53:1217-19.
92. Correa P. The biological model of gastric carcinogenesis. IARC Scientific Publications 2004;
157:301-10.
93. Rugge M, Correa P, Dixon MF, Hattori T, Leandro G, Lewin K, et al. Gastric dysplasia: the
Padova international classification. Am J Surg Pathol 2000; 24:167-76.
94. Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, et al. Progression of
chronic atrophic gastritis associated with H pylori infection increases risk of gastric
cancer. Int J Cacer 2004; 109:138-43.
95. Tahara E. Genetic pathways of two types of gastric cancer. IARC Scientific Publications 2004;
157:327-49.
96. Kameda T, Yasui W, Yoshida K, Tsujino T, Nakayama H, Ito M, et al. Expression of ErbB2 in
human gstric carcinomas: relationship between p185 ErbB2 expression and the gene
amplification. Cancer Res 1990; 50:8002-9.
97. Yonemura Y, Ninomiya I, Ohoyama S, Kimura H, Yamaguchi A, Fushida S, et al. Expression of
cerbB-2 oncoprotein in gastric carcinoma: immunoreactivity for cerbB-2 protein is an
indepndent indicator of poor short term prognosis in patients with gastric carcinoma.
Cancer 1991; 67:2914-18.